ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "psoriatic arthritis and spondylarthropathy"

  • Abstract Number: 579 • 2012 ACR/ARHP Annual Meeting

    Prevalence of Psoriatic Arthritis in Psoriasis Patients According to Newer Classification Criteria

    Hernan Maldonado-Ficco1, Gustavo Citera1, Ana Alba Porrini2 and Jose A. Maldonado-Cocco1, 1Rheumatology, Instituto de Rehabilitacion Psicofisica - Fundacion Reumatologica Argentina Dr. Osvaldo Garcia-Morteo, Buenos Aires, Argentina, 2Rheumatology, Hospital Argerich, Buenos Aires, Argentina

    Background/Purpose:  To determine the prevalence of Psoriatic Arthritis (PsA) in a cohort of psoriasis patients according to CASPAR criteria, and compare it with that resulting from…
  • Abstract Number: L4 • 2012 ACR/ARHP Annual Meeting

    Continued Improvement of Signs and Symptoms  in Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

    Arthur Kavanaugh1, Iain B. McInnes2, Alice B. Gottlieb3, Lluis Puig4, Proton Rahman5, Christopher T. Ritchlin6, Shu Li7, Yuhua Wang7, Mittie K. Doyle8 and Alan M. Mendelsohn9, 1UCSD School of Medicine, La Jolla, CA, 2University of Glasgow, Glasgow, Scotland, 3Tufts Medical Center, Boston, MA, 4Universitat Autònoma de Barcelona, Barcelona, Spain, 5Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 6Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 7Janssen Research & Development, LLC., Spring House, PA, 8Janssen Research & Development, LLC, Spring House, PA, 9Immunology, Janssen Research & Development, LLC., Spring House, PA

    Background/Purpose: PSUMMIT I ,through wk24, demonstrated efficacy and safety of ustekinumab (UST) in reducing signs and symptoms of active psoriatic arthritis (PsA) in a large,…
  • Abstract Number: 2616 • 2012 ACR/ARHP Annual Meeting

    The Transition From Psoriasis (Ps) to Psoriatic Arthritis (PsA) Is Associated with Elevated Circulating Osteoclast Precursors (OCP) and Increased Expression of DC-STAMP

    Ya-Hui Chiu1, Edward M. Schwarz2, Dafna D. Gladman3, Sharon Moorehead4, Michelle Smith4, Rick Barrett4 and Christopher T. Ritchlin4, 1Allergy, Immunology, and Rheumatology, University of Rochester, Rochester, NY, 2Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 3Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 4Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY

    Background/Purpose: Approximately 20% of psoriasis (Ps) patients (pts) develop psoriatic arthritis (PsA). Early diagnosis and therapy of PsA can limit bone and joint damage; however,…
  • Abstract Number: 1616 • 2012 ACR/ARHP Annual Meeting

    Comparison of Conventional and Wholebody Magnetic Resonance Imaging for Assessing Inflammation and Structural Damage in Psoriatic Arthritis and Axial Spondyloarthritis

    René Panduro Poggenborg1, Susanne Juhl Pedersen2, Iris Eshed3, Inge Juul Sørensen4, Ole Rintek Madsen5, J.M. Møller6 and Mikkel Østergaard7, 1Department of Rheumatology, Copenhagen University Hospital in Glostrup, Copenhagen, Denmark, 2Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 3Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel, 4Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 5Department of Rheumatology, Copenhagen University Hospital in Gentofte, Copenhagen, Denmark, 6Department of Radiology, Copenhagen University Hospital in Herlev, Copenhagen, Denmark, 7Copenhagen University Hospital Glostrup, Glostrup, Denmark

    Background/Purpose: Wholebody magnetic resonance imaging (WBMRI) is a new imaging modality where patients are scanned from “head to toe” in one single scan, but with…
  • Abstract Number: 1381 • 2012 ACR/ARHP Annual Meeting

    Non-Radiographic  Spondyloarthritis Has Greater Work Instability Than Other Spondyloarthritis Subtypes in a National Database

    Sherry Rohekar1, Robert D. Inman2, Renise Ayearst3, Proton Rahman4, Walter P. Maksymowych5 and Dafna D. Gladman6, 1Rheumatology, St. Joseph's Hospital, London, ON, Canada, 2Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 5Department of Medicine, University of Alberta, Edmonton, AB, Canada, 6Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, University Health Network, Toronto, ON, Canada

    Background/Purpose: Clinical subsets of spondyloarthritis (SpA), such as ankylosing spondylitis (AS) and psoriatic arthritis (PsA) can be associated with significant impact on work performance and…
  • Abstract Number: 1356 • 2012 ACR/ARHP Annual Meeting

    Gender Differences Among Spondylitis Associated with Psoriasis, Inflammatory Bowel Disease and Primary Ankylosing Spondylitis

    Margarita Landi1, Hernan Maldonado-Ficco2, Jose A. Maldonado-Cocco2, Gustavo Citera3, Pablo Arturi2, Percival Sampaio-Barros4, Diana Flores5, Ruben Burgos-Vargas6, Helena Santos7, Jose Chavez-Corrales8, Daniel Palleiro9, Miguel A. Gutierrez10, Elsa Vieira-Sousa11, Fernando Pimentel-Santos12, Sergio O. Paira13, Alberto Berman Sr.14, Janitzia Vazquez-Mellado15, Eduardo Collantes-Estevez16 and On behalf of RESPONDIA Group17, 1Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitacion Psicofisica and Fundacion Reumatologica Argentina, Buenos Aires, Argentina, 3Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Rheumatology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil, 5Rheumatology, Hospital Universitario, Monterrey, Mexico, 6Rheumatology, Hospital General de Mexico, Mexico DF, Mexico, 7Rheumatology, Instituto Português de Reumatologia, Lisboa, Portugal, 8Rheumatology, Hospital Nacional E. Rebagliti-ESSALUD, Lima, Peru, 9Rheumatology, Instituto Nacional de Reumatologia, Montevideo, Uruguay, 10Rheumatology and Inmunology, Pontificia Universidad Catolica de Chile, Santiago, Chile, 11Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, 12Rheumatology, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, 13Hospital Jose María Cullen, Santa Fe SFE S3000BFP, Argentina, 14Internal Medicine, Hospital Padilla, Tucuman, Argentina, 15Rheumatology, Hospital General de Mexico, Mexico city, Mexico, 16Depatamento de Medicina, IMIBIC-Reina Sofia Hospital, Cordoba 14012, Spain, 17Buenos Aires

    Background/Purpose: Differences regarding gender in primary Ankylosing Spondylitis are well known. However, there is less evidence regarding Spondylitis Associated with Psoriasis and that associated with…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology